Oral Session
Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.12 (Osaka International Convention Center, 10F 1006-7)
Chair: Naoki Mori (Tokyo Women's Medical University, Japan)
【Ｅ】
Yoshikane Kikushige, Toshihiro Miyamoto, Koichi Akashi (Department of Medicine and Biosystemic Sciences, Kyushu University, Fukuoka, Japan)
Schedule
Like
)
Takanori Teshima1, Hirohiko Shibayama2, Ilseung Choi3, Kiyohiko Hatake4, Naohiro Sekiguchi5, Nozomi Yoshinari6 (1.Faculty of Medicine, Hokkaido Univ., Sapporo, Japan, 2.Osaka Univ. Grad. Schl. Med., Osaka, Japan, 3.NHO Kyusyu Cancer Ctr., Fukuoka, Japan, 4.The Cancer Institute Hosp. JFCR, Tokyo, Japan, 5.NHO Disaster Med. Ctr., Tachikawa, Japan, 6.Janssen Pharmaceutical K.K, Tokyo, Japan)
Schedule
Like
)
Kohei Okada, Akio Shigematsu, Naoki Miyashita, Koichiro Minauchi, Junko Iwasaki, Shinpei Harada, Shojiro Takahashi, Tomohiro Yamakawa, Masahiro Ogasawara, Masahiro Imamura, Naoki Kobayashi, Shuichi Ota (Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan)
Schedule
Like
)
Ajay Gogia, Vinod Raina, Lalit kumar, Atul Sharma, Ritu Gupta (ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS), NEW DELHI, INDIA)
Schedule
Like
)
Suguru Fukuhara1, Koji Izutsu1,2, Tomohiro Kinoshita3,4, Jun Takizawa5, Yasuo Ohashi6, Junji Suzumiya7, Kensei Tobinai1 (1.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 3.Dept. Hematology/Cell Therapy, Aichi Cancer Center, Nagoya, Japan, 4.Japanese Red Cross Aichi Blood Center, Seto, Japan, 5.Dept. Hematology/Endocrinology/Metabolism, Niigata University Faculty of Medicine, Niigata, Japan, 6.Faculty of Science and Engineering, Chuo University, Tokyo, Japan, 7.Innovative Cancer Center/Oncology-Hematology, Shimane University Hospital, Izumo, Japan)
Schedule
Like
)
Paolo Ghia1, Peter Hillmen2, Carol Moreno3, Stephan Stilgenbauer4, Thomas Webb5, Anil Lohnde6, Angela Howes5, Michelle Mahler6, Nishan Sengupta6, Mark Wildgust6 (1.Universita Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milano, Italian Republic, 2.The Leeds Teaching Hospitals, St James Institute of Oncology, Leeds, United Kingdom of Great Britain and Northern Ireland, 3.Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 4.Department of Internal Medicine, Division of Hematology, University of Ulm, Ulm, Federal Republic of Germany, 5.Janssen Research & Development, High Wycombe, United Kingdom of Great Britain and Northern Ireland, 6.Janssen Research and Development, Raritan, United States of America)
Schedule
Like
)